Back

Heparin does not improve myocardial glucose metabolism suppression in patients with low betahydroxybutyrate level

30 August 2024 (12:00 - 12:40)
Organised by: Logo
Congress Presentation Part of: Positron emission tomography innovations in diagnosis and prognosis Inflammation, Infection, and Infiltrative Cardiovascular Disorders ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Suvi Hartikainen

University of Eastern Finland, Kuopio (Finland)

6 More presentations in this session

Presentation thumbnail
Usefulness of visual classification for cardiac pathophysiology using count-washout rate map in iodine-123-beta-methyl-P-iodophenyl-pentadecanoic acid scintigraphy
Doctor R. Ono (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Assessment of impact of left ventricular flow state on myocardial blood flow using positron emission tomography and echocardiography
Doctor M. Pu (New York, US) Doctor B. Chen (Bronx, US)
Abstract Slides Video
Presentation thumbnail
Predictive value of cardiac 18F-fluorodeoxyglucose positron emission tomography for fatal ventricular arrhythmic events in patients with cardiac sarcoidosis
Doctor K. Takeuchi (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
18F-FDG PET/CT in the diagnosis of infective endocarditis
Miss L. Salminen (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Hypoperfused myocardium and systolic function in patients with AMI undergoing complete revascularization
Doctor J. Si (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Positron emission tomography innovations in diagnosis and prognosis

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Patient preparation: a necessary evil!
thumbnail
Congress Presentation
Acute hemodynamic effect of oral ketones in patients with acutely decompensated heart failure and low cardiac output syndrome: a prospective randomized study.
thumbnail
Congress Presentation
Circulating beta-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources